Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial
Olsson, Tomas, Boster, Aaron, Fernández, Óscar, Freedman, Mark S, Pozzilli, Carlo, Bach, Doris, Berkani, Ouali, Mueller, Markus S, Sidorenko, Tatiana, Radue, Ernst-Wilhelm, Melanson, Maria
Published in Journal of neurology, neurosurgery and psychiatry (01.11.2014)
Published in Journal of neurology, neurosurgery and psychiatry (01.11.2014)
Get full text
Journal Article
Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference
Black, Jed, MD, Pillar, Giora, MD, PhD, Hedner, Jan, MD, PhD, Polo, Olli, MD, PhD, Berkani, Ouali, Mangialaio, Sara, MD, PhD, Hmissi, Abdel, MSc, MBA, Zammit, Gary, PhD, Hajak, Goran, MD, PhD
Published in Sleep medicine (01.08.2017)
Published in Sleep medicine (01.08.2017)
Get full text
Journal Article
LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials
Navarra, Sandra V, Cornelisse, Peter, Cahuzac, Clélia, Yokoyama, Yoshinari, Togo, Osamu, Ouali Berkani
Published in Lupus science & medicine (01.07.2023)
Published in Lupus science & medicine (01.07.2023)
Get full text
Journal Article
LO-016 The multifaceted immunomodulatory properties of cenerimod, a selective S1P1 receptor modulator, target three key aspects of SLE pathogenesis
Hoyler, Thomas F, Strasser, Daniel S, Ouali Berkani, Cahuzac, Clelia, Cornelisse, Peter, Murphy, Mark J, Martinic, Marianne M
Published in Lupus science & medicine (01.07.2023)
Published in Lupus science & medicine (01.07.2023)
Get full text
Journal Article